本页面由Tiger Trade Technology Pte. Ltd.提供服务

CALIDI BIOTHERAPEUTICS INC

0.9499
-0.0801-7.78%
盘前:0.9200-0.0299-3.15%07:46 EDT
成交量:5.30万
成交额:5.13万
市值:350.11万
市盈率:-0.03
高:0.9980
开:0.9980
低:0.9371
收:1.03
52周最高:27.84
52周最低:0.9371
股本:368.58万
流通股本:365.71万
量比:1.48
换手率:1.45%
股息:- -
股息率:- -
每股收益(TTM):-33.3374
每股收益(LYR):-95.1334
净资产收益率:-672.22%
总资产收益率:-134.79%
市净率:1.12
市盈率(LYR):-0.01

数据加载中...

2024/01/08

SEC问询函

Form CORRESP - Correspondence
2024/01/08

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/05

重要事件披露

Form 8-K - Current report
2023/12/19

重要事件披露

Form 8-K - Current report
2023/12/12

SEC问询函

Form CORRESP - Correspondence
2023/12/12

重要事件披露

Form 8-K - Current report
2023/12/12

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/12/05

重要事件披露

Form 8-K - Current report
2023/11/15

重要事件披露

Form 8-K - Current report
2023/11/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/30

重要事件披露

Form 8-K - Current report
2023/10/28

重要事件披露

Form 8-K - Current report
2023/10/25

重要事件披露

Form 8-K/A - Current report: [Amend]
2023/10/16

重要事件披露

Form 8-K - Current report
2023/10/10

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/10/06

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2023/09/30

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/26

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/09/26

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership